MALDI mass spectrometry imaging has emerged as a powerful technology platform for spatially resolved analysis and visualization of a wide range of molecules – including drugs, metabolites, peptides and more – in pharmaceutical R&D, clinical research and basic science. Advances in MALDI workflows are making the technique more accessible.
In this webinar, our speaker will discuss how a new MALDI workflow can be used to analyze lipids in degenerative disease and Alzheimer’s models, contextualizing lipid distribution by enabling comparison to multiple protein markers.
He’ll also highlight how the new workflow can be applied to the study of tumor subtypes and the tumor microenvironment.

A major challenge when developing AAV-based therapeutics is ensuring that empty AAVs that lack therapeutic DNA are removed, increasing the efficacy of the product.

Explore the latest knowledge on the safety, authenticity and quality of food and beverages, as well as the technology that supports the critical work done to ensure the integrity of the food supply chain.

This webinar presents the latest innovation in bioseparations that can help biopharma QC lab to overcome these challenges increasing efficiency and reducing costs.

This webinar provides essential strategies and technologies for achieving error-free method transfers, scaling and operation.

Advances in monoclonal antibody (mAb) engineering have led to additional challenges in the purification of these modalities, including high levels of aggregates. Ion exchange chromatography is often not sufficient to achieve purity targets meaning hydrophobic interaction chromatography (HIC) and mixed-mode resins are needed as orthogonal tools. These technologies can be implemented in flow-through mode allowing for high loadings and fast processing times, making them well-suited for large-scale implementation.

This webinar highlights three case studies that illustrate how novel chromatographic tools can improve the purification process for complex therapeutics by reducing the levels of aggregates and host cell proteins (HCPs) and effectively clearing retroviruses.